Flemington, NJ has 4 licensed drug and alcohol treatment facilities listed in SAMHSA's FindTreatment.gov data: 1 provide residential (inpatient) care, 3 offer medication-assisted treatment, and 3 accept NJ FamilyCare. Compare levels of care, insurance accepted and accreditation below.
Flemington, NJ 08822
Joint Commission accredited
Levels of care
Payment accepted
Medicaid · Medicare · Private insurance +3 more
“Get help” calls our free helpline, not this facility.
Flemington, NJ 08822
Levels of care
Payment accepted
Self-pay · Sliding scale · State-funded
“Get help” calls our free helpline, not this facility.
Flemington, NJ 08822
Levels of care
Payment accepted
Medicaid · Private insurance · TRICARE +2 more
“Get help” calls our free helpline, not this facility.
Flemington, NJ 08822
Levels of care
Payment accepted
Medicaid · Medicare · Private insurance +2 more
“Get help” calls our free helpline, not this facility.
Our directory lists 4 licensed substance use treatment facilities in Flemington, NJ, based on SAMHSA's FindTreatment.gov data (updated October 2026). Listings include outpatient, residential, detox and medication-assisted treatment programs.
No facilities in Flemington, NJ list detox services in SAMHSA's data. Nearby cities may offer detox, or call (877) 847-2855 and an admissions specialist can help you find the closest option.
3 facilities in Flemington, NJ report accepting Medicaid (NJ FamilyCare). Coverage depends on your plan and the program's network, so confirm before admission.
3 facilities in Flemington, NJ accept private health insurance. Benefits vary by plan (deductibles, prior authorization, in- vs. out-of-network). Call (877) 847-2855 for a free insurance check.
1 facility in Flemington, NJ offer residential (inpatient) treatment, where you live on site 24/7 while in care. Learn more about inpatient rehab.
Yes. 3 programs in Flemington, NJ use FDA-approved medications such as buprenorphine, naltrexone or methadone. See our guide to MAT.
Source: SAMHSA FindTreatment.gov, data updated October 2026. Listings are not endorsements.
